Vivani Medical
VANI
55 hedge funds and large institutions have $9.56M invested in Vivani Medical in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 9 closing their positions.
112% more call options, than puts
Call options by funds: $280K | Put options by funds: $132K
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
4% less funds holding
Funds holding: 57 → 55 (-2)
6% less capital invested
Capital invested by funds: $10.2M → $9.56M (-$631K)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$431K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$164K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$159K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$102K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$57K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCIM
51
TIAA CREF Investment Management
New York
| $183 | – | – | – |
|
|
52
Goldman Sachs
New York
| – | -$431K | -5,021 | Closed |
|
|
CS
53
Credit Suisse
Zurich,
Switzerland
| – | -$159K | -1,856 | Closed |
|
|
54
AQR Capital Management
Greenwich,
Connecticut
| – | -$102K | -1,180 | Closed |
|
|
TSS
55
Two Sigma Securities
New York
| – | -$57K | -666 | Closed |
|
|
FTI
56
Fiduciary Trust International
Lincoln,
Massachusetts
| – | -$50K | -588 | Closed |
|
57
Millennium Management
New York
| – | -$36K | -423 | Closed |
|
58
Barclays
London,
United Kingdom
| – | -$3.89K | -44 | -92% |
|
59
JP Morgan Chase
New York
| – | -$3K | -35 | Closed |
|
|
TRCT
60
Tower Research Capital (TRC)
New York
| – | -$1K | -14 | Closed |
|
|
AG
61
Advisor Group
Phoenix,
Arizona
| – | -$797 | -9 | -69% |
|
|
GT
62
Glenmede Trust
Philadelphia,
Pennsylvania
| – | +$89 | +1 | New |
|
|
VCM
63
Versant Capital Management
Phoenix,
Arizona
| – | +$177 | +2 | New |
|
VANI Hedge Fund Activity: Q3 2016 in Review
55 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2016, worth a combined $9.56M — down 6.2% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of VANI and 7 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 17 added.
The largest buyer was BlackRock Fund Advisors, adding an estimated $211K. The largest seller was Goldman Sachs, exiting entirely with an estimated $431K sold.
- 55 institutional investors held Vivani Medical (VANI) as of Q3 2016, down from 57 in Q2 2016.
- Funds reported $9.56M of Vivani Medical stock for Q3 2016, down 6.2% quarter-over-quarter.
- 7 funds opened new Vivani Medical positions in Q3 2016 and 9 closed out, a net change of -2 holders.
- The largest Vivani Medical buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $211K added.
- The largest Vivani Medical seller in Q3 2016 was Goldman Sachs, an estimated $431K sold.
Based on aggregated 13F filings for Q3 2016.